MedTrace Logo

EMBA Peripheral Embolization Device ("EPED") Study

NCT02335788 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2022-07-28

No results posted yet for this study

Summary

This is an open label, acute, non-randomized, prospective, "first in man" (FIM) single-center study of the EMBA Medical Peripheral Embolization Device (PED).

Conditions

  • Peripheral Embolization

Interventions

DEVICE

The EMBA Peripheral Embolization Device

arterial and venous embolization in the peripheral vasculature

Sponsors & Collaborators

  • EMBA Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Andrew Holden, MD · Auckland City Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-08-31
Completion
2016-08-31

Countries

  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02335788 on ClinicalTrials.gov